<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Så nåede ofatumumab op på studie 63 på clinical trials:]]></title><description><![CDATA[<p dir="auto">Så nåede ofatumumab op på studie 63 på clinical trials:<br />
Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)<br />
This study is not yet open for participant recruitment.<br />
Verified on September 2011 by M.D. Anderson Cancer Center<br />
First Received on September 28, 2011.   Last Updated on September 30, 2011</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448377/s-nede-ofatumumab-op-p-studie-63-p-clinical-trials</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 05:42:57 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448377.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 04 Oct 2011 06:34:34 GMT</pubDate><ttl>60</ttl></channel></rss>